Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenhalgh, C. J.
Right arrow Articles by Hilton, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenhalgh, C. J.
Right arrow Articles by Hilton, D. J.
(Journal of Leukocyte Biology. 2001;70:348-356.)
© 2001 by Society for Leukocyte Biology

Negative regulation of cytokine signaling

Christopher J. Greenhalgh and Douglas J. Hilton

The Walter and Eliza Hall Institute of Medical Research and the Cooperative Research Centre for Cellular Growth Factors, Parkville, Victoria, Australia

Correspondence: Dr. Christopher J. Greenhalgh, The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. E-mail: greenhalgh{at}wehi.edu.au

Cytokines use complex signaling cascades to elicit their biological effects, many of which involve phosphorylation as a mechanism of activation. Rapid and efficient attenuation of cytokine signals is crucial to maintaining regulation of these processes and to preventing toxic side effects. Phosphatases have been shown to be involved in these regulatory processes, but more recent research has seen the discovery of two new families of negative regulators, the suppressor of cytokine signaling (SOCS) and protein inhibitors of signal transducer and activator of transcription (STAT) (PIAS) protein families. SOCS proteins are induced by and inhibit many cytokine-signaling systems in a classic negative-feedback loop, and the generation of transgenic and knockout models has greatly increased our understanding of their physiological functions. PIAS proteins interact with the transcriptional mediators of cytokine action, the STATs, to suppress their DNA-binding activity. These three classes of molecules form what is now emerging as an integrated system for deactivating cytokine signaling at a number of levels, from the receptor to the transcription factor.

Key Words: SOCS • Janus kinase • STAT • PIAS • phosphatase




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Pichiorri, S.-S. Suh, M. Ladetto, M. Kuehl, T. Palumbo, D. Drandi, C. Taccioli, N. Zanesi, H. Alder, J. P. Hagan, et al.
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
PNAS, September 2, 2008; 105(35): 12885 - 12890.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Duechting, C. Tschope, H. Kaiser, T. Lamkemeyer, N. Tanaka, S. Aberle, F. Lang, J. Torresi, R. Kandolf, and C.-T. Bock
Human Parvovirus B19 NS1 Protein Modulates Inflammatory Signaling by Activation of STAT3/PIAS3 in Human Endothelial Cells
J. Virol., August 15, 2008; 82(16): 7942 - 7952.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Shen, S.-S. Zheng, O. Park, H. Wang, Z. Sun, and B. Gao
Activation of innate immunity (NK/IFN-{gamma}) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation
Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G1070 - G1077.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yan, J.-K. Luo, K. J. Ritchie, I. Sakai, K. Takeuchi, R. Ren, and D.-E. Zhang
Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling
Blood, July 1, 2007; 110(1): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. C. Choi, R. Holtz, M. G. Petroff, N. Alfaidy, and S. P. Murphy
Dampening of IFN-{gamma}-Inducible Gene Expression in Human Choriocarcinoma Cells Is Due to Phosphatase-Mediated Inhibition of the JAK/STAT-1 Pathway
J. Immunol., February 1, 2007; 178(3): 1598 - 1607.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. M. Pello, M. del Carmen Moreno-Ortiz, J. M. Rodriguez-Frade, L. Martinez-Munoz, D. Lucas, L. Gomez, P. Lucas, E. Samper, M. Aracil, C. Martinez-A, et al.
SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade
Blood, December 1, 2006; 108(12): 3928 - 3937.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. A. Dennis, A. Jefferson, S. R. Singh, F. Ganapamo, and M. T. Philipp
Interleukin-10 Anti-Inflammatory Response to Borrelia burgdorferi, the Agent of Lyme Disease: a Possible Role for Suppressors of Cytokine Signaling 1 and 3.
Infect. Immun., October 1, 2006; 74(10): 5780 - 5789.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Li, N. Chu, A. Rostami, and G.-X. Zhang
Dendritic Cells Transduced with SOCS-3 Exhibit a Tolerogenic/DC2 Phenotype That Directs Type 2 Th Cell Differentiation In Vitro and In Vivo
J. Immunol., August 1, 2006; 177(3): 1679 - 1688.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Ben-Zvi, A. Yayon, A. Gertler, and E. Monsonego-Ornan
Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling
J. Cell Sci., January 15, 2006; 119(2): 380 - 387.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J G Miquet, A I Sotelo, A Bartke, and D Turyn
Increased SH2-B{beta} content and membrane association in transgenic mice overexpressing GH
J. Endocrinol., May 1, 2005; 185(2): 301 - 306.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. Olivier, D. J. Gregory, and G. Forget
Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View
Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Takatori, H. Nakajima, S.-i. Kagami, K. Hirose, A. Suto, K. Suzuki, M. Kubo, A. Yoshimura, Y. Saito, and I. Iwamoto
Stat5a Inhibits IL-12-Induced Th1 Cell Differentiation through the Induction of Suppressor of Cytokine Signaling 3 Expression
J. Immunol., April 1, 2005; 174(7): 4105 - 4112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Takatori, H. Nakajima, K. Hirose, S.-i. Kagami, T. Tamachi, A. Suto, K. Suzuki, Y. Saito, and I. Iwamoto
Indispensable Role of Stat5a in Stat6-Independent Th2 Cell Differentiation and Allergic Airway Inflammation
J. Immunol., March 15, 2005; 174(6): 3734 - 3740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-J. Kim, J.-I. Park, and B. D. Nelkin
IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells
J. Biol. Chem., February 11, 2005; 280(6): 4913 - 4920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Spight, B. Zhao, M. Haas, S. Wert, A. Denenberg, and T. P. Shanley
Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo
Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L251 - L265.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. R. Boverhof, E. Tam, A. S. Harney, R. B. Crawford, N. E. Kaminski, and T. R. Zacharewski
2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Suppressor of Cytokine Signaling 2 in Murine B Cells
Mol. Pharmacol., December 1, 2004; 66(6): 1662 - 1670.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Daniels, K. Shimizu, A. M. Zorn, and S.-i. Ohnuma
Negative regulation of Smad2 by PIASy is required for proper Xenopus mesoderm formation
Development, November 15, 2004; 131(22): 5613 - 5626.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. L. Chelvarajan, S. M. Collins, I. E. Doubinskaia, S. Goes, J. Van Willigen, D. Flanagan, W. J. S. de Villiers, J. S. Bryson, and S. Bondada
Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens
J. Leukoc. Biol., June 1, 2004; 75(6): 982 - 994.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Suppression of Growth Hormone (GH) Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 5 Signaling Pathway in Transgenic Mice Overexpressing Bovine GH
Endocrinology, June 1, 2004; 145(6): 2824 - 2832.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Gomez-Guerrero, O. Lopez-Franco, G. Sanjuan, P. Hernandez-Vargas, Y. Suzuki, G. Ortiz-Munoz, J. Blanco, and J. Egido
Suppressors of Cytokine Signaling Regulate Fc Receptor Signaling and Cell Activation during Immune Renal Injury
J. Immunol., June 1, 2004; 172(11): 6969 - 6977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Goldshmit, C. E. Walters, H. J. Scott, C. J. Greenhalgh, and A. M. Turnley
SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation
J. Biol. Chem., April 16, 2004; 279(16): 16349 - 16355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Gatto, C. Berlato, V. Poli, S. Tininini, I. Kinjyo, A. Yoshimura, M. A. Cassatella, and F. Bazzoni
Analysis of SOCS-3 Promoter Responses to Interferon {gamma}
J. Biol. Chem., April 2, 2004; 279(14): 13746 - 13754.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. S. Rawlings, K. M. Rosler, and D. A. Harrison
The JAK/STAT signaling pathway
J. Cell Sci., March 15, 2004; 117(8): 1281 - 1283.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. S. Grutkoski, Y. Chen, C. S. Chung, and A. Ayala
Sepsis-induced SOCS-3 expression is immunologically restricted to phagocytes
J. Leukoc. Biol., November 1, 2003; 74(5): 916 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kim, J. M. Suh, E. S. Hwang, D. W. Kim, H. K. Chung, J. H. Song, J. H. Hwang, K. C. Park, H. K. Ro, E.-K. Jo, et al.
Thyrotropin-Mediated Repression of Class II Trans-Activator Expression in Thyroid Cells: Involvement of STAT3 and Suppressor of Cytokine Signaling
J. Immunol., July 15, 2003; 171(2): 616 - 627.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Gu, N. Dube, J. W. Kim, A. Cheng, M. d. J. Ibarra-Sanchez, M. L. Tremblay, and Y. R. Boisclair
Protein Tyrosine Phosphatase 1B Attenuates Growth Hormone-Mediated JAK2-STAT Signaling
Mol. Cell. Biol., June 1, 2003; 23(11): 3753 - 3762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. A. Khabar, Y. M. Siddiqui, F. Al-Zoghaibi, L. Al-Haj, M. Dhalla, A. Zhou, B. Dong, M. Whitmore, J. Paranjape, M. N. Al-Ahdal, et al.
RNase L Mediates Transient Control of the Interferon Response through Modulation of the Double-stranded RNA-dependent Protein Kinase PKR
J. Biol. Chem., May 23, 2003; 278(22): 20124 - 20132.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Galm, H. Yoshikawa, M. Esteller, R. Osieka, and J. G. Herman
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma
Blood, April 1, 2003; 101(7): 2784 - 2788.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
O. A. Malakhova, M. Yan, M. P. Malakhov, Y. Yuan, K. J. Ritchie, K. I. Kim, L. F. Peterson, K. Shuai, and D.-E. Zhang
Protein ISGylation modulates the JAK-STAT signaling pathway
Genes & Dev., February 15, 2003; 17(4): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. C.H Ng, N. W Court, C. G dos Remedios, and M. A Bogoyevitch
Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts
Cardiovasc Res, February 1, 2003; 57(2): 333 - 346.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Kuwata, C. Gongora, Y. Kanno, K. Sakaguchi, T. Tamura, T. Kanno, V. Basrur, R. Martinez, E. Appella, T. Golub, et al.
Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element
Mol. Cell. Biol., November 1, 2002; 22(21): 7439 - 7448.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Greenhalgh, D. Metcalf, A. L. Thaus, J. E. Corbin, R. Uren, P. O. Morgan, L. J. Fabri, J.-G. Zhang, H. M. Martin, T. A. Willson, et al.
Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling
J. Biol. Chem., October 18, 2002; 277(43): 40181 - 40184.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. Zolk, L. L. Ng, R. J. O'Brien, M. Weyand, and T. Eschenhagen
Augmented Expression of Cardiotrophin-1 in Failing Human Hearts Is Accompanied by Diminished Glycoprotein 130 Receptor Protein Abundance
Circulation, September 17, 2002; 106(12): 1442 - 1446.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. E. Timsit and D. S. Riddick
Stimulation of Hepatic Signal Transducer and Activator of Transcription 5b by GH Is Not Altered by 3-Methylcholanthrene
Endocrinology, September 1, 2002; 143(9): 3284 - 3294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Berlato, M. A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni
Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation
J. Immunol., June 15, 2002; 168(12): 6404 - 6411.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Buettner, L. B. Mora, and R. Jove
Activated STAT Signaling in Human Tumors Provides Novel Molecular Targets for Therapeutic Intervention
Clin. Cancer Res., April 1, 2002; 8(4): 945 - 954.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Leukocyte Biology.